- September 24, 2020
- Organized By:
Sponsored by the U.S. Food & Drug Administration (FDA)
Pam Balcazar, MS—Cancer Patient Caretaker/Senior Regulatory Project Manager, Office of Oncologic Diseases, FDA
Marcia Cruz-Correa, MD, PhD, AGAF, FASGE—Executive Director/Professor of Medicine & Biochemistry, University of Puerto Rico Comprehensive Cancer
Ysabel Duron—President/Executive Director, The Latino Cancer Institute
Jorge Nieva, MD—Associate Professor of Clinical Medicine, University of Southern California
Amelie Ramirez, DrPH, MPH—Chair and Professor, University of Texas Health Science Center of San Antonio/Associate Director, Mays Cancer Center Community Outreach and Engagement
Georgia Sadler, BSN, MBA, PhD—Emeritus Professor, Department of Surgery at the University of California San Diego School of Medicine
Latinos are underrepresented in cancer clinical trials and genomic databases that capture information leading to the development of cancer treatments. What are actions the oncology community can take to improve recruitment and inclusion of Latino subgroups in cancer clinical trials?
Please join FDA's Oncology Center of Excellence for a dynamic panel discussion about barriers and opportunities to achieving equity in cancer clinical trials by increasing participation in the Latino community.
FDA provided a free-of-charge, live webcast of this workshop.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov